|
AU2015264960A1
|
|
Intravaginal Device Comprising Anticholinergic Agents, And Methods Of Making Thereof
|
|
AU2015258221A1
|
|
Methods of Treating Conditions Associated with Overactive Bladder
|
|
AU2015200367A1
|
|
Dosage regimens and pharmaceutical compositions and packagse for emergency contraception
|
|
WO2014143617A1
|
|
Deuterium-enriched tanaproget and processes for its preparation
|
|
WO2014159377A1
|
|
Compositions containing tanaproget and natural estrogens
|
|
MX2013002016A
|
|
Intravaginal devices, methods of making, and uses thereof.
|
|
AU2011203526A1
|
|
Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
|
|
EP2566877A1
|
|
Methods of reducing symptoms in subjects using single dosage forms with tapering release rates
|
|
EA022208B1
|
|
Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
|
|
AU2007338843A1
|
|
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
AU2006330846A1
|
|
Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
|
|
US2007107200A1
|
|
Method for making a lollipop
|
|
NZ585546A
|
|
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
|
|
MX2013000002A
|
|
Differential interferometric scanning near-field confocal microscopy.
|
